4
项与 地舒单抗生物类似药(Xentria) 相关的临床试验A Randomized, Double-blind, Parallel-group, Active-controlled Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of MAB-22 Versus Prolia® Sourced From the European Union in Postmenopausal Women With Osteoporosis
Double-blind, Parallel-group, Active-controlled Study to Compare the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of MAB-22 Versus Prolia®
A Randomized, Double-blind, Controlled, Parallel-group, Single Dose, Three-arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Versus Prolia® Sourced From the European Union and United States in Healthy Male Participants
A Randomized, Double-blind, Controlled, Parallel-group, Single Dose, Three-arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Versus Prolia®
100 项与 地舒单抗生物类似药(Xentria) 相关的临床结果
100 项与 地舒单抗生物类似药(Xentria) 相关的转化医学
100 项与 地舒单抗生物类似药(Xentria) 相关的专利(医药)
100 项与 地舒单抗生物类似药(Xentria) 相关的药物交易